Company research
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK 1742927Updated Sep 29, 2026
SecurityRVPH · OTC · equity
Name history
Tenzing Acquisition Corp. · through Dec 14, 2020
RVPH price & chart
Loading TradingView…
OTC:RVPH on TradingView ↗In the news
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering ↗
Recent filings
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Other Events
Items 3.01, 8.01
Show 5 more recent filings
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
424B5 filing
424B5 filing
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 15,923,198Source | 15,503,088Source | 23,700,388Source | 18,923,675Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 14,438,792Source | 13,476,331Source | 23,367,456Source | 18,519,856Source |
| Assets, CurrentUSD | 15,103,477Source | 14,683,367Source | — | — |
| Prepaid Expense and Other Assets, CurrentUSD | 664,685Source | 666,435Source | 332,932Source | 403,819Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 7,275,553Source | 14,690,516Source | 17,981,672Source | 6,607,279Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | — |
| Common Stock, Value, IssuedUSD | 11,655Source | 4,658Source | 2,792Source | 2,045Source |
| Additional Paid in CapitalUSD | 192,773,942Source | 165,080,964Source | 140,070,172Source | 103,485,612Source |
| Retained Earnings (Accumulated Deficit)USD | -184,137,952Source | -164,273,050Source | -134,354,248Source | -91,171,261Source |
| Stockholders' Equity Attributable to ParentUSD | 8,647,645Source | 812,572Source | 5,718,716Source | 12,316,396Source |
| Liabilities and EquityUSD | 15,923,198Source | 15,503,088Source | 23,700,388Source | 18,923,675Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 7,275,553Source | 14,601,506Source | 17,175,017Source | 6,039,840Source |
| Accounts Payable, CurrentUSD | 3,009,074Source | 6,283,430Source | 3,849,108Source | 3,520,271Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,227,859Source | 1,630,341Source | 3,413,354Source | 176,735Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -3,407,773Source | 2,291,186Source | 328,837Source | 3,010,688Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -24,594,643Source | -33,543,916Source | -28,324,353Source | -18,960,581Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 25,557,104Source | 23,652,791Source | 33,171,953Source | 7,792,493Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 13,402Source | 18,497Source | 30,622Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 2,227,859Source | 1,630,341Source | 3,413,354Source | 176,735Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 89,010Source | 717,645Source | -239,216Source | -194,709Source |
| General and Administrative ExpenseUSD | 8,491,125Source | 7,891,521Source | 8,083,819Source | 5,358,734Source |
| Income Tax Expense (Benefit)USD | 18,889Source | 19,514Source | 16,949Source | 20,777Source |
| InterestExpenseNonoperatingUSD | 13,402Source | 18,497Source | — | — |
| Investment Income, InterestUSD | 311,370Source | 361,369Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -19,864,902Source | -29,918,802Source | -39,260,837Source | -24,339,292Source |
| Nonoperating Income (Expense)USD | 354,018Source | 899,601Source | 259,748Source | -11,907Source |
| Operating ExpensesUSD | 20,200,031Source | 30,798,889Source | 39,503,636Source | 24,306,608Source |
| Operating Lease, ExpenseUSD | 55,400Source | 50,180Source | — | — |
| Other Nonoperating Income (Expense)USD | -32,960Source | -160,916Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -20,200,031Source | -30,798,889Source | -39,503,636Source | -24,306,608Source |
| Other Nonoperating Income (Expense)USD | -32,960Source | -160,916Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -19,846,013Source | -29,899,288Source | -39,243,888Source | -24,318,515Source |
| Income Tax Expense (Benefit)USD | 18,889Source | 19,514Source | 16,949Source | 20,777Source |
| Net Income (Loss) Attributable to ParentUSD | -19,864,902Source | -29,918,802Source | -39,260,837Source | -24,339,292Source |
| Earnings Per Share, BasicUSD per share | -5.48Source | -0.9Source | -1.65Source | -1.25Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 3,627,890Source | 33,147,424Source | 23,798,203Source | 19,516,479Source |
| Interest Expense (non-operating)USD | 13,402Source | 18,497Source | — | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 18,889Source | 19,514Source | 16,949Source | 21,000Source |
| Gain (Loss) on Derivative Instruments, Net, PretaxUSD | 89,010Source | 717,645Source | -239,216Source | -194,709Source |
| General and Administrative ExpenseUSD | 8,491,125Source | 7,891,521Source | 8,083,819Source | 5,358,734Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -19,934,208Source | -29,847,961Source | -39,301,700Source | -24,363,000Source |
| Investment Income, InterestUSD | 311,370Source | 361,369Source | — | — |
| Nonoperating Income (Expense)USD | 354,018Source | 899,601Source | 259,748Source | -11,907Source |
| Operating ExpensesUSD | 20,200,031Source | 30,798,889Source | 39,503,636Source | 24,306,608Source |
| Operating Lease, ExpenseUSD | 55,400Source | 50,180Source | — | — |
| Research and Development ExpenseUSD | 11,708,906Source | 22,907,368Source | 31,419,817Source | 18,947,874Source |